ALPINE IMMUNE SCIENCES, INC. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2014-11-25. The offering totals $40.0M, of which $30.0M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 30 people.
| Name | Role | Location |
|---|---|---|
| Howard Furst | Director | Boulder, CO |
| Jonathan Leff | Director | Ness Ziona, L3 |
| Evan Loh | Director | Boulder, CO |
| JOSEPH LOSCALZO | Director | WALTHAM, MA |
| John Moore | Director | Charlottesville, VA |
| Tom Sokolowski | Executive Officer | Boulder, CO |
| Stanford Paul Peng | Executive Officer | Seattle, WA |
| Robert Paul Conway | Director | Seattle, WA |
| Peter Paul Thompson | Director | Seattle, WA |
| Jay Paul Venkatesan | Director | Seattle, WA |
| Zelanna Paul Goldberg | Executive Officer | Seattle, WA |
| Natasha Paul Hernday | Director | Seattle, WA |
| James Paul Rickey | Executive Officer | Seattle, WA |
| Cui Paul Xiangmin | Director | Seattle, WA |
| Mitchell Paul Gold | Director | Seattle, WA |
| Mitchell Paul Gold | Executive Officer | Seattle, WA |
| James Paul Topper | Director | Seattle, WA |
| Christopher Paul Peetz | Director | Seattle, WA |
| Paul Paul Sekhri | Director | Seattle, WA |
| Jay James Venkatesan | Director | Seattle, WA |
| Mitchell James Gold | Director | Seattle, WA |
| Mitchell James Gold | Executive Officer | Seattle, WA |
| James James Topper | Director | Seattle, WA |
| Mark James Litton | Executive Officer | Seattle, WA |
| Cui James Xiangmin | Director | Seattle, WA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2021-09-29 | D | $91.0M | $91.0M |
| 2020-08-07 | D | $82.7M | $60.0M |
| 2019-01-30 | D | $48.7M | $25.3M |